1. "2017"
  2. "American Society of Hematology"
Formats
  1. Meeting Abstract (182)
  2. Journal Article (64)
Groups
  1. Department of Medicine (214)
  2. Center for Hematologic Malignancies (209)
  3. Hematologic Malignancies, Division of (206)
  4. Adult Leukemia (83)
  5. GSK Faculty (82)
  6. Executive Committee, Center for Hematologic Malignancies (72)

More Groups

People
  1. Martin Tallman (32)
  2. Omar Abdel-Wahab (20)
  3. Sergio Giralt (20)
  4. Steven Horwitz (19)
  5. Ahmet Dogan (18)
  6. Ross Levine (16)

More People

Years
  1. 2017 (246)
Publications
  1. Blood (233)
  2. Blood Advances (9)
  3. Hematology-American Society of Hematology Education Program (4)
Publishers
  1. American Society of Hematology (246)

Results (246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scFv) immune checkpoint blockade
    Meeting Abstract

    Rafiq, S.; Jackson, H. J.; Yeku, O.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Ahmed, R. N.; Cullen, G. D.; Yan, S.; Wang, P.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Adults receiving defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final results from the expanded-access program
    Meeting Abstract

    Richardson, P. G.; Antin, J. H.; Giralt, S. A.; Ryan, R. J.; Liang, W.; Hume, R. L.; Tappe, W. M.; Kernan, N. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Pooled analysis of day +100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) and ventilator or dialysis dependence following hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Richardson, P. G.; Smith, A. R.; Kernan, N. A.; Antin, J. H.; Lehmann, L.; Ryan, R. J.; Hume, R. L.; Tappe, W. M.; Grupp, S. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Results from ENESTgoal: A phase 2 study of treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) who switched from imatinib to nilotinib
    Meeting Abstract

    Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Pinilla-Ibarz, J.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Dautaj, I.; Purkayastha, D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post-transplant lymphoproliferative disorder
    Meeting Abstract

    Prockop, S.; Li, A.; Baiocchi, R. A.; Bunin, N.; Mahadeo, K. M.; Nemecek, E. R.; Nikiforow, S.; Reshef, R.; Tsai, D. E.; Navarro, W. H.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling
    Meeting Abstract

    Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
    Blood (2017)

    Fulltext@MSK | Save
  • RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Meeting Abstract

    Premsrirut, P.; Wang, C. L.; Yang, Y. T.; Fellmann, C.; Dow, L.; Zuber, J.; Lowe, S.; Pesic, M.; Wolter, K.; Zender, L.
    Blood (2017)

    Fulltext@MSK | Save
  • Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
    Meeting Abstract

    Quek, L.; David, M.; Kennedy, A.; Metzner, M.; Amatangelo, M.; Shih, A. H.; Stoilova, B.; Karamitros, D.; Quivoron, C.; Heiblig, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Systematic combinatorial chimeric antigen receptor therapies to AML
    Meeting Abstract

    Perna, F.; Berman, S.; Soni, R. K.; Mansilla-Soto, J.; Eyquem, J.; Hamieh, M.; Hendrickson, R. C.; Brennan, C.; Sadelain, M.
    Blood (2017)

    Fulltext@MSK | Save